Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

SF3B1 inhibitor

DRUG CLASS:

SF3B1 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

SF3B1 K666N	Endometrial Cancer	SF3B1 K666N	Endometrial Cancer	SSA Sensitive: D – Preclinical SSA Sensitive : D	SSA Sensitive: D – Preclinical SSA Sensitive : D
SF3B1 K700E	Estrogen Receptor Positive Breast Cancer	SF3B1 K700E	Estrogen Receptor Positive Breast Cancer	SSA Sensitive: D – Preclinical SSA Sensitive : D	SSA Sensitive: D – Preclinical SSA Sensitive : D
SF3B1 K666Q	Estrogen Receptor Positive Breast Cancer	SF3B1 K666Q	Estrogen Receptor Positive Breast Cancer	SSA Sensitive: D – Preclinical SSA Sensitive : D	SSA Sensitive: D – Preclinical SSA Sensitive : D
SF3B1 K666E	Estrogen Receptor Positive Breast Cancer	SF3B1 K666E	Estrogen Receptor Positive Breast Cancer	SSA Sensitive: D – Preclinical SSA Sensitive : D	SSA Sensitive: D – Preclinical SSA Sensitive : D
SRSF2 P95H	Acute Myelogenous Leukemia	SRSF2 P95H	Acute Myelogenous Leukemia	E7107 Sensitive: D – Preclinical E7107 Sensitive : D	E7107 Sensitive: D – Preclinical E7107 Sensitive : D
SF3B1 K700E	Pancreatic Cancer	SF3B1 K700E	Pancreatic Cancer	SSA Sensitive: D – Preclinical SSA Sensitive : D	SSA Sensitive: D – Preclinical SSA Sensitive : D